Skip to main content
David Ting, MD, Oncology, Boston, MA

DavidTsaiTingMD

Oncology • Boston, MA

Assistant Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Join to view full profile

Dr. Ting is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ting's full profile

Already have an account?

  • Office

    55 Fruit St
    Boston, MA 02114
    Phone+1 617-724-4000

Summary

  • Dr. David Ting is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Harvard Medical School and has been in practice 13 years.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2004 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2025
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • The Histologic Diagnosis of IgG4‐Related Disease on Small Biopsies: Challenges and Pitfalls  
    Vikram Deshpande, David T Ting, Histopathology

Press Mentions

  • Study Reveals How Cancer Immunotherapy Leads to Deadly Form of Heart Inflammation in Some Patients
    Study Reveals How Cancer Immunotherapy Leads to Deadly Form of Heart Inflammation in Some PatientsNovember 6th, 2024
  • Oncology Round-up: Distinguishing Prostate Cancer Lesions, Reverse Transcriptase Inhibitors; And More
    Oncology Round-up: Distinguishing Prostate Cancer Lesions, Reverse Transcriptase Inhibitors; And MoreApril 15th, 2022
  • Reverse Transcriptase Inhibitors Used in HIV Therapies Stop Disease Progression in Metastatic Colorectal Cancer
    Reverse Transcriptase Inhibitors Used in HIV Therapies Stop Disease Progression in Metastatic Colorectal CancerApril 12th, 2022
  • Join now to see all

Professional Memberships

Dr. David Ting, Dr. David Ting, MD, Dr. D Ting, Dr. David Tsai Ting